NEW YORK (GenomeWeb) – Lophius Biosciences today announced it received a €2.0 million ($2.8 million) investment to fund clinical studies of its flagship product and to develop new products.

The firm also announced a new CEO and changes to its board.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.